Cita APA

Fitzhugh, C. D., Cordes, S., Taylor, T., Coles, W., Roskom, K., Link, M., . . . Tisdale, J. F. (2017). At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT. Blood.

Chicago Style Citation

Fitzhugh, Courtney D., Stefan Cordes, Tiffani Taylor, Wynona Coles, Katherine Roskom, Mary Link, Matthew M. Hsieh, i John F. Tisdale. "At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype After Allogeneic HSCT." Blood 2017.

Cita MLA

Fitzhugh, Courtney D., et al. "At Least 20% Donor Myeloid Chimerism Is Necessary to Reverse the Sickle Phenotype After Allogeneic HSCT." Blood 2017.